共 50 条
- [1] Impact of cytochrome P450 2C19 polymorphisms on the pharmacokinetics of tacrolimus when coadministered with voriconazole [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (04): : 408 - 413
- [2] Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 Genotype [J]. JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (12): : 1941 - 1948
- [3] The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro [J]. INFECTION AND DRUG RESISTANCE, 2018, 11 : 2129 - 2135
- [5] Cytochrome P450 2C19 genetic polymorphisms in Ugandans [J]. European Journal of Clinical Pharmacology, 2009, 65 : 319 - 320
- [6] Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19 [J]. The Pharmacogenomics Journal, 2005, 5 : 365 - 373
- [7] Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism [J]. Clinical Pharmacokinetics, 2002, 41 : 913 - 958
- [8] Human Cytochromes P450: Focus on Cytochrome P450 2C19 [J]. DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1698 - 1711
- [9] GENETIC POLYMORPHISM OF CYTOCHROME P450 (2C19) IN PATIENTS WITH RENAL TRANSPLANT [J]. TISSUE ANTIGENS, 2014, 84 (01): : 58 - 59
- [10] Effects of Cytochrome P450 (CYP) 2C19 Genetic Polymorphisms on Voriconazole Serum Levels: A Report of Two Cases [J]. MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2021, 10